My Locations
Gary C. Werths Building at Siteman Cancer Center
Siteman Cancer Center at Northwest HealthCare
Expertise & Training
Clinical Expertise
Multiple myeloma and cellular therapies, including bone marrow transplant and CAR T-cell therapy
Primary Academic Title
Assistant Professor of Medicine, Clinical Oncology, WashU Medicine
Board Certification
- 2020: American Board of Internal Medicine, General
- 2022: American Board of Internal Medicine, Oncology
Training
- 2017 - 2020: Internal Medicine Resident, WashU Medicine, St. Louis, MO
- 2020 - 2023: Hematology/Oncology Fellow (Chief Fellow), WashU Medicine, St. Louis, MO
Education
- 2017: MD, WashU Medicine, St. Louis, MO
- 2017: MSCI, WashU Medicine, St. Louis, MO
Research & Selected Publications
Research Interest
Dr. Slade’s current research is focused on cellular immunotherapy and plasma cell dyscrasias, including multiple myeloma and its precursor states. His laboratory-based research is focused on understanding mechanisms of chimeric antigen receptor (CAR) T cell failure in patients with multiple myeloma, including tumor evolution, modulation of the immune microenvironment and CAR T cell exhaustion. His clinical research is focused on the role of autologous stem cell transplant in multiple myeloma and on advanced methods of disease monitoring following myeloma treatment, including ultra- sensitive next generation sequencing, flow cytometry and mass spectrometry.
Research Publications